Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
Publishing timestamp: 2023-06-20 21:12:16
Summary
Novo Nordisk sues medical spas and wellness clinics for selling unauthorized versions of weight loss drugs Ozempic and Wegovy. The company is seeking court orders to block sales of counterfeit medicines and unspecified damages. The lawsuits come amid a shortage of the drugs, leading to a rise in compounded alternatives that claim to be popular injections. FDA has warned about safety risks of unauthorized versions of the drugs.
Sentiment: NEGATIVE
Tickers: NOVO.B-DK,
Keywords: products and services, health care industry, biotech and pharmaceuticals, business news, laws, pharmaceuticals, novo nordisk a/s, business, biotechnology,
Source: https://www.cnbc.com/2023/06/20/ozempic-wegovy-knockoffs-novo-nordisk-suit.html